[Sudden cardiac death : Epidemiology, pathophysiology and risk stratification]

Related Experiment Video

Updated: Mar 7, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

880

B Rudic1,2, E Tülümen3,4, V Liebe3,4

  • 1I. Medizinische Klinik, Abteilung für Kardiologie, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. boris.rudic@umm.de.

Herz
|February 24, 2017
PubMed

Insights

Sudden cardiac death (SCD) is a significant health issue. Implantable cardioverter defibrillator (ICD) therapy and catheter ablation are key strategies for preventing fatal arrhythmias and reducing mortality risk in high-risk patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Public Health

Background:

  • Sudden cardiac death (SCD) remains a major public health concern despite advances in ventricular tachyarrhythmia treatment.
  • Survivors of sudden cardiac arrest face a high risk of recurrent tachyarrhythmia.
  • Low left ventricular ejection fraction (≤35%) is a strong predictor of mortality and is causally linked to SCD.

Purpose of the Study:

  • To review current strategies for the prevention of sudden cardiac death.
  • To highlight the role of implantable cardioverter defibrillator (ICD) therapy in primary and secondary prevention.
  • To discuss the efficacy of catheter ablation in reducing ventricular tachyarrhythmia recurrence.

Main Methods:

  • Review of current literature on sudden cardiac death prevention.
  • Analysis of the application of implantable cardioverter defibrillator (ICD) therapy.
  • Evaluation of electrophysiological catheter ablation techniques for ventricular tachyarrhythmia.

Main Results:

  • Implantable cardioverter defibrillator (ICD) therapy is standard for primary prevention in patients with cardiomyopathy and electrical syndromes, and for secondary prevention in survivors.
  • Pharmacological antiarrhythmic therapy and device-based prevention have significantly developed.
  • Complex electrophysiological catheter ablation procedures effectively reduce ventricular tachyarrhythmia recurrence.

Conclusions:

  • Implantable cardioverter defibrillator (ICD) therapy is crucial for preventing sudden cardiac death in high-risk populations.
  • Catheter ablation offers an effective adjunctive therapy for managing recurrent ventricular tachyarrhythmias.
  • Continued research and application of these therapies are vital for reducing the burden of SCD.

Keywords:
Ablation proceduresAntiarrhythmic therapyICD therapySudden cardiac deathVentricular tachyarrhythmia

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.2K

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
497
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
847
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
443
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722